1. Home
  2. KLTR vs CCCC Comparison

KLTR vs CCCC Comparison

Compare KLTR & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kaltura Inc.

KLTR

Kaltura Inc.

HOLD

Current Price

$1.71

Market Cap

238.4M

Sector

Technology

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.03

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLTR
CCCC
Founded
2006
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
238.4M
240.3M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
KLTR
CCCC
Price
$1.71
$2.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$3.50
$7.25
AVG Volume (30 Days)
348.9K
2.0M
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$180,921,000.00
$30,108,000.00
Revenue This Year
$3.10
N/A
Revenue Next Year
$1.24
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.88
N/A
52 Week Low
$1.36
$1.09
52 Week High
$2.82
$4.26

Technical Indicators

Market Signals
Indicator
KLTR
CCCC
Relative Strength Index (RSI) 55.78 35.76
Support Level $1.64 $2.00
Resistance Level $1.72 $2.13
Average True Range (ATR) 0.09 0.16
MACD 0.01 -0.06
Stochastic Oscillator 63.46 12.65

Price Performance

Historical Comparison
KLTR
CCCC

About KLTR Kaltura Inc.

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: